Clopidogrel: A Viewpoint by David H. Fitchett

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.6, 2001-06, pp. : 475-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel: A Viewpoint by Robert M. Califf

By Califf R.M.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 476-476

Adis International

Access to resources Recommend Favorite

Fomivirsen: A Viewpoint by David W. Johnson

By Johnson D.W.

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 381-381

Adis International

Access to resources Recommend Favorite

Donepezil in Vascular Dementia: A Viewpoint by David S. Geldmacher

By Geldmacher D.S.

Drugs & Aging, Vol. 20, Iss. 15, 2003-01 ,pp. : 1137-1138

Adis International

Access to resources Recommend Favorite

Pioglitazone/Metformin: A Viewpoint by David R. Matthews

By Matthews David R.

Drugs, Vol. 66, Iss. 14, 2006-01 ,pp. : 1878-1880

Adis International

Access to resources Recommend Favorite

Lamivudine/Zidovudine/Abacavir: A Viewpoint by David Haas

By Haas D.

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1099-1100

Adis International

Access to resources Recommend Favorite